211 related articles for article (PubMed ID: 19223536)
1. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
Tworoger SS; Gates MA; Lee IM; Buring JE; Titus-Ernstoff L; Cramer D; Hankinson SE
Cancer Res; 2009 Mar; 69(5):1885-91. PubMed ID: 19223536
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Hollis BW; Giovannucci E
Prostate; 2007 Jun; 67(9):911-23. PubMed ID: 17440943
[TBL] [Abstract][Full Text] [Related]
3. Associations between polymorphisms in the vitamin D receptor and breast cancer risk.
Chen WY; Bertone-Johnson ER; Hunter DJ; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2335-9. PubMed ID: 16214913
[TBL] [Abstract][Full Text] [Related]
4. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Receptor Polymorphisms and Cancer.
Gnagnarella P; Raimondi S; Aristarco V; Johansson HA; Bellerba F; Corso F; Gandini S
Adv Exp Med Biol; 2020; 1268():53-114. PubMed ID: 32918214
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
7. VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population.
Singh I; Lavania M; Pathak VK; Ahuja M; Turankar RP; Singh V; Sengupta U
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006823. PubMed ID: 30481178
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.
Iqbal Mu; Khan TA; Maqbool SA
PLoS One; 2015; 10(3):e0122657. PubMed ID: 25799416
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor polymorphisms and cancer.
Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S
Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361
[TBL] [Abstract][Full Text] [Related]
10. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.
Dasgupta S; Dutta J; Annamaneni S; Kudugunti N; Battini MR
Indian J Med Res; 2015 Sep; 142(3):276-85. PubMed ID: 26458343
[TBL] [Abstract][Full Text] [Related]
11. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
Tang C; Chen N; Wu M; Yuan H; Du Y
Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
[TBL] [Abstract][Full Text] [Related]
12. The Association Between
Duan GQ; Zheng X; Li WK; Zhang W; Li Z; Tan W
Genet Test Mol Biomarkers; 2020 May; 24(5):285-295. PubMed ID: 32255717
[No Abstract] [Full Text] [Related]
13. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.
Randerson-Moor JA; Taylor JC; Elliott F; Chang YM; Beswick S; Kukalizch K; Affleck P; Leake S; Haynes S; Karpavicius B; Marsden J; Gerry E; Bale L; Bertram C; Field H; Barth JH; Silva Idos S; Swerdlow A; Kanetsky PA; Barrett JH; Bishop DT; Bishop JA
Eur J Cancer; 2009 Dec; 45(18):3271-81. PubMed ID: 19615888
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.
Raza S; Dhasmana A; Bhatt MLB; Lohani M; Arif JM
Asian Pac J Cancer Prev; 2019 Jan; 20(1):199-206. PubMed ID: 30678432
[TBL] [Abstract][Full Text] [Related]
16. Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies.
Hou W; Wan X; Fan J
BMC Genet; 2015 Feb; 16():14. PubMed ID: 25887475
[TBL] [Abstract][Full Text] [Related]
17. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer.
Fuhrman BJ; Freedman DM; Bhatti P; Doody MM; Fu YP; Chang SC; Linet MS; Sigurdson AJ
Anticancer Res; 2013 Feb; 33(2):543-51. PubMed ID: 23393347
[TBL] [Abstract][Full Text] [Related]
18. Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.
Incel Uysal P; Alli N; Hayran Y; Candar T
Acta Dermatovenerol Croat; 2018 Apr; 26(1):8-14. PubMed ID: 29782293
[TBL] [Abstract][Full Text] [Related]
19. The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.
Atoum MF; AlKateeb D; AlHaj Mahmoud SA
Asian Pac J Cancer Prev; 2015; 16(6):2227-30. PubMed ID: 25824742
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the Vitamin D Receptor Gene and Sex-Differential Associations with Lipid Profiles in Chinese Han Adults.
Chen YM; Xu P; Wang ZT; Zhu YM; Gong CM; Huang CH; Liu XL; Zhou JC
Biomed Environ Sci; 2022 Feb; 35(2):115-125. PubMed ID: 35197176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
